Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Relative Strength
MEDS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
2024-Revenue
2024-EPS
2024-EBITDA
Analyst rating
No Data Available
Last analyst upgrade/downgrade
No Data Available
Earnings Growth
YoY
Current
Estimates
Q2.22
N/A
-1.95
vs -2.55
Q3.22
N/A
-0.90
vs -2.39
Q4.22
N/A
-1.50
vs -1.35
Q1.23
N/A
-0.45
vs -1.80
Q2.23
N/A
-0.77
vs -1.95
Q3.23
N/A
-4.57
vs -0.90
Q4.23
N/A
-0.07
vs -1.50
Q1.24
N/A
-6.40
vs -0.45
Q2.24
N/A
-1.04
vs -0.77
Q3.24
N/A
-0.15
vs -4.57
Sales Growth
YoY
Current
Estimates
Q3.22
-6%
2.4M vs 2.6M
Q4.22
+6%
2.5M vs 2.4M
Q1.23
-31%
2.2M vs 3.2M
Q2.23
-31%
2.3M vs 3.3M
Q3.23
-14%
2.1M vs 2.4M
Q4.23
-7%
2.4M vs 2.5M
Q1.24
-100%
NA vs 2.2M
Q2.24
-99%
18.7K vs 2.3M
Q3.24
+20%
2.5M vs 2.1M
Q4.24
+8%
2.5M vs 2.4M
Return on Equity
QoQ
Q3.22
-36%
-0.36
vs -0.60
Q4.22
-232%
-2.32
vs -0.36
Q1.23
-10%
-0.10
vs -2.32
Q2.23
+153%
1.53
vs -0.10
Q3.23
-30%
-0.30
vs 1.53
Q4.23
-2160%
-21.60
vs -0.30
Q1.24
-62%
-0.62
vs -21.60
Q2.24
-16%
-0.16
vs -0.62
Institutionnal Ownership
QoQ
Q3.21
10
10
vs 10
NA
Q4.21
13
13
vs 10
30%
Q1.22
12
12
vs 13
-8%
Q2.22
13
13
vs 12
8%
Q3.22
12
12
vs 13
-8%
Q4.22
14
14
vs 12
17%
Q1.23
11
11
vs 14
-21%
Q2.23
1
1
vs 11
-91%
globenewswire.com
8 hours ago
globenewswire.com
8 hours ago
globenewswire.com
8 hours ago
globenewswire.com
11 hours ago
globenewswire.com
16 hours ago
globenewswire.com
16 hours ago